The Franklin Institute is proud to announce nine outstanding individuals being honored with a prestigious Franklin Institute Award for their extraordinary scientific, engineering, and business leadership achievements.
Dr. Palmer brings significant expertise both as a clinical oncologist and as a high-level executive at several national laboratories. His prior industry roles include CMO at Tempus Labs, VP of Medical Affairs at Foundation Medicine, and VP of Medical Affairs at Genomic Health.
The New York Genome Center (NYGC) announced the launch of the MacMillan Center for the Study of the Non-Coding Cancer Genome (MCSNCG) today, a major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in the evolution, progression, and treatment of multiple cancer types, including breast, ovary, pancreas, gastrointestinal, lung, and hematologic cancers.
The award-winning CeCe Migraine Management app now offers users an unprecedented level of insight into their migraine treatments with the CEFALY Connected device.
APRINOIA Therapeutics Inc. ("APRINOIA"), a clinical-stage biotechnology company focused on neurodegenerative diseases such as Alzheimer's Disease ("AD") and Progressive Supranuclear Palsy ("PSP"), and Ross Acquisition Corp II (NYSE: ROSS, ROSS.U, ROSS WS) ("ROSS"), a special purpose acquisition company founded by former Commerce Secretary Wilbur Ross, today announced that they have entered into a definitive agreement (the "Business Combination Agreement") for a business combination (the "Business Combination").
Hearst Health, in partnership with the UCLA Center for SMART Health, today announced that the call for submissions is open for the 2023 Hearst Health Prize, an annual award that recognizes data science projects and programs demonstrating improved health outcomes for U.S. populations.
Arthrex, a global leader in minimally invasive surgical technology, announced today its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications.
Stuart Therapeutics, Inc. announces that it has expanded its drug development pipeline, adding programs in diabetic macular edema and myopia.
Stuart Therapeutics, Inc., (hereinafter Stuart) announces that it has entered into a license agreement with AJU Pharm Co. Ltd. (hereinafter AJU), for Stuart's clinical stage drug candidate ST-100.
ApolloMD announces a partnership with Cascade365 to work in concert with RIP Medical Debt, resulting in the successful abolishment of more than $350M of patient medical debt spanning over 800,000 patient accounts. Recipients of debt abolishment began receiving notification by way of a RIP branded letter beginning in the month of June.
Golden State Dermatology (GSD) is pleased to announce a new partnership with the dermatology practice of Emil Tanghetti, MD located in Sacramento, CA. The new partnership expands GSD's network to 28 practices across the San Francisco Bay and California's Central Valley and Sacramento Valley.
Medical device maker CEFALY Technology has announced that owners of older CEFALY devices can trade them in for credit toward the purchase of the all-new CEFALY Connected.
Medical device maker CEFALY Technology today unveiled the newest evolution of its FDA-cleared migraine treatment device: the CEFALY Connected.
AnX Robotica Corporation (www.anxrobotics.com), the developer and manufacturer of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE), is pleased to announce a partnership with GastroGPO, a Specialty Networks Company.
DrSnip, a new vasectomy clinic in Portland, is offering a limited time discounted vasectomy for any patients who do not have insurance, or whose plans are not contracted with DrSnip.
The Petfood Consumer Rights Council, a first-of-its-kind consumer protection and animal welfare organization, has launched and announced its first key initiative, a 90-day founding member drive.
Jurata Thin Film, a startup focused on stabilizing vaccines at ambient temperature has raised initial investment funds totaling $4.87 million to develop the technology.
Arthrex and Richard Wolf, global leaders in minimally invasive surgical technology and solutions, announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.
Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the closing of a $20 million Series A financing.
Accure Acne, Inc. (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today it has received FDA clearance for its Accure Laser™ System to treat mild to severe inflammatory acne vulgaris.
MIM Software Inc., a leading global provider of medical imaging software, announced today it has released a new version of its AI auto-contouring solution, Contour ProtégéAI™ Version 1.1.3.
CO2 isotope measurements are a critical tool for studying climate change and for modelling future climate scenarios.
RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services has been selected by Wellcome Leap to participate in the $50M In Utero program to create the scalable capacity to measure, model and predict gestational development, to achieve the goal of reducing global stillbirth rates by half.
Unlikely Collaborators has made a significant monetary investment in SIY Global, kicking-off a partnership that will see the two companies working together in a myriad of ways, including product and curriculum development, teacher training, and content creation.
Researchers at MedStar Health, Brigham and Women's Hospital, and the University of Utah found electronic health record (EHR) vendor misconduct may have led to widespread use of suboptimal products for more than 70,000 clinicians across the country, as published today in JAMA Health Forum.
Hyperproof, a pioneer in SaaS based security and compliance operations management, announced today the release of a suite of new functionality to help global enterprise organizations operating in complex environments manage their risks and compliance programs at scale.
Resolve Therapeutics, pioneering first-in-class, targeted, safe therapies for underserved autoimmune diseases, today announced that its phase 2 clinical trial of RSLV-132 in patients with long covid has been fully enrolled (NCT04944121).
Despite centuries of research, treating and curing cancer remains an urgent health research priority. With generous support from anonymous donors, the GastroIntestinal Research Foundation (GIRF) has launched a bold initiative, CA CURE, to identify and fund research to improve diagnostics and develop therapeutics focused on immunotherapies and personalized vaccines.
Somatus, the nation's leading and largest value-based kidney care company, has received a 2022 Validation Program Report certifying the claim that kidney disease patients who receive Somatus Transition of Care Assessment (TCA) services have fewer hospital readmissions than similar patients who do not receive TCA services.
The Alzheimer's Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November.
MIM Software Inc., a leading global provider of medical imaging software, announced today it has received approval from Health Canada for its AI auto-contouring solution, Contour ProtégéAI™.
W. L. Gore & Associates initiates its GORE® VIAFORT Device Pivotal Clinical Study for the treatment of inferior vena cava occlusive disease.
ScienceMedia has joined Biocom California at the Provider level of membership, connecting to more than 1,700 member companies and 500,000 employees across California and beyond.
The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, today announced the three finalists for the 2022 Hearst Health Prize, a $100,000 award given in recognition of excellence in data science for managing or improving health in the U.S.
United BioChannels (UBC), a commercial strategy consultancy, announced its acquisition of ORFLO Technologies, LLC, from Gemini Bioproducts.
School-based telehealth provider releases impact report following one year of dramatic expansion during the nation's youth mental health crisis.
Xtremis, LLC (Xtremis), a Nashville-based startup developing advanced, Artificial Intelligence control systems that improve the performance of wireless networks in congested RF environments, recently announced its intention to relocate to Morgantown, WV.
COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system for the treatment of autoimmune disorders (COUR NanoParticles or CNPs), today announced that the U.S. Food and Drug Administration has cleared an Investigational New Drug (IND) application to initiate a Phase 1b/2a proof-of-concept study of COUR's investigational therapy, CNP-106.
Process-innovation leader ImageSource, Inc. has rolled out a new flagship website at ImageSourceInc.com.
Vasa Therapeutics, Inc., a preclinical stage company developing first-in-class treatments for cardiovascular indications with limited or no available therapies, today announced two upcoming poster presentations showing data on the company's lead clinical candidate, VS-041, a selective matrix metalloprotease (MMP) inhibitor for treatment of heart failure with preserved ejection fraction (HFpEF) and the discovery of novel calcium/calmodulin-dependent protein kinase II delta (CaMKIIδ) inhibitors for treatment of β-blocker resistant arrythmias, at the American Heart Association (AHA) Scientific Sessions November 5 – 7 in Chicago, IL.
The Vilcek Foundation announces the recipients of the 2023 Vilcek Foundation Prizes. Awarded annually in the arts and sciences, the prizes recognize and celebrate immigrant contributions to the arts, culture, and society, and build awareness of how important immigration is for intellectual and cultural life in the United States.
GQR Global Markets announced today that it has been named #7 on Staffing Industry Analysts' (SIA) 2022 List of Fastest-Growing Staffing Firms for the 5th year in a row. Even more exceptional is the fact that GQR is the only firm to rank in the top ten for four of the last five years and within the top sixteen every year for the last five years.
Riverside Oral Surgery, the premier oral and maxillofacial surgery group in New Jersey, has been named one of the Best Places to Work (medium market employer) in 2022 by NJBIZ.
Partnership will deliver healthcare education and resources to an estimated 27.7 million members of the African- American and Latino communities on a multitude of therapeutic areas and disease states.
It's likely many Americans think of September as the start of football season or the beginning of a new school year.
Retrace, a leader in dental artificial intelligence and provider of digital infrastructure for U.S. healthcare, announces the publication, "A generative adversarial inpainting network to enhance prediction of periodontal clinical attachment level" in the August 2022 Edition of the Journal of Dentistry.
Lactose-reduced infant formula made with corn syrup solids was associated with higher obesity risk among Special Supplemental Nutrition Program for Women, Infants and Children (WIC) participants in Southern California, according to a new study by researchers from Public Health Foundation Enterprises (PHFE) WIC, a program of Heluna Health; and Children's Hospital Los Angeles.
The American Physical Society (APS), publisher of the prestigious Physical Review journals, has appointed Rachel Burley as its first Chief Publications Officer (CPO). In this new role, Burley will manage more than a dozen leading peer-reviewed journals.
Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical trials for its eQUANT system, which will be used to support a submission for FDA clearance.
The National Policing Institute (the Institute) is proud to announce and welcome Robin S. Engel, PhD as the Institute's Senior Vice President, becoming the second highest-ranking executive within the national non-profit research and policy organization dedicated to excellence in policing and community safety through science and innovation.
Showing results
1–50 of 481
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
